supplementary tables: Real-world use and acceptance of biosimilar monoclonal antibodies of rituximab in oncology practice in the USA.docx
收藏数据链接：
官方服务：
资源简介：
<b>Supplementary Table 1</b>. Definitions of Dosing and Treatment Patterns Variables <b>Supplementary Table 2</b>. Treatment Utilization Patterns of Rituximab-pvvr in Patients with NHL and CLL Real-World Use and Acceptance of Biosimilar Monoclonal Antibodies of Rituximab in Oncology Practice in the United States
提供机构：
Taylor & Francis创建时间：
2021-07-14
